Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2440356
Max Phase: Preclinical
Molecular Formula: C31H47N9O7S
Molecular Weight: 689.84
Molecule Type: Small molecule
Associated Items:
ID: ALA2440356
Max Phase: Preclinical
Molecular Formula: C31H47N9O7S
Molecular Weight: 689.84
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccc(/C=C2\SC(=O)N(CCO)C2=O)cc1)C(N)=O
Standard InChI: InChI=1S/C31H47N9O7S/c1-2-3-7-21(25(33)42)37-27(44)22(8-4-5-14-32)39-28(45)23(9-6-15-36-30(34)35)38-26(43)20-12-10-19(11-13-20)18-24-29(46)40(16-17-41)31(47)48-24/h10-13,18,21-23,41H,2-9,14-17,32H2,1H3,(H2,33,42)(H,37,44)(H,38,43)(H,39,45)(H4,34,35,36)/b24-18-/t21-,22-,23-/m0/s1
Standard InChI Key: YDDWEGMOSAZUNS-SKHVONHGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 689.84 | Molecular Weight (Monoisotopic): 689.3319 | AlogP: -0.15 | #Rotatable Bonds: 21 |
Polar Surface Area: 275.92 | Molecular Species: BASE | HBA: 10 | HBD: 9 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.21 | CX Basic pKa: 15.67 | CX LogP: -1.36 | CX LogD: -6.02 |
Aromatic Rings: 1 | Heavy Atoms: 48 | QED Weighted: 0.04 | Np Likeness Score: -0.44 |
1. Nitsche C, Schreier VN, Behnam MA, Kumar A, Bartenschlager R, Klein CD.. (2013) Thiazolidinone-peptide hybrids as dengue virus protease inhibitors with antiviral activity in cell culture., 56 (21): [PMID:24083834] [10.1021/jm400828u] |
Source(1):